Stay updated on Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page.

Latest updates to the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedExpanded the Study Details page to include a broader Locations section with numerous new trial sites across the United States, Australia, and other countries.SummaryDifference2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedPublications section wording updated to indicate publications are automatically filled from PubMed, with Revision: v3.3.2 added. The previous text implying that publications come directly from PubMed was removed.SummaryDifference0.1%

- Check47 days agoChange DetectedA general government funding/status notice was removed from the page. All trial details, eligibility criteria, and links remain unchanged.SummaryDifference0.2%

- Check61 days agoChange DetectedThere were only minor UI and text updates; no changes to core study details, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check90 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check97 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page.